Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$42.34 - $52.82 $11.5 Million - $14.3 Million
-270,906 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$36.12 - $50.05 $24,417 - $33,833
-676 Reduced 0.25%
270,906 $13.6 Million
Q3 2020

Nov 12, 2020

BUY
$38.56 - $48.36 $7.66 Million - $9.61 Million
198,626 Added 272.25%
271,582 $11.4 Million
Q2 2020

Aug 13, 2020

BUY
$44.5 - $52.11 $3.25 Million - $3.8 Million
72,956 New
72,956 $3.54 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Ars Investment Partners, LLC Portfolio

Follow Ars Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Investment Partners, LLC with notifications on news.